Disruption of Smad5 gene leads to enhanced proliferation of high-proliferative potential precursors during embryonic hematopoiesis

Blood

Volumn 101, Issue 1, 2003, Pages 124-133

  Liu, Bing ^a   Sun, Yanxun ^a   Jiang, Feizi ^a   Zhang, Shuangxi ^a   Wu, Ying ^a   Lan, Yu ^a   Yang, Xiao ^a   Mao, Ning ^a  

^a Yan Jing Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; SMAD PROTEIN; SMAD5 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR RUNX1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLONY FORMING CELL; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ERYTHROID PRECURSOR CELL; GENE; GENE DISRUPTION; GENE DOSAGE; HEMATOPOIESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMAD5 GENE; STEM CELL; WILD TYPE; YOLK SAC;

EID: 0037222682     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-02-0398     Document Type: Article

References (64)

1. Heldin CH, Miyazono K, Dijke P. TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature. 1997;390:465-471.
2. Massague J. TGF-β signal transduction. Annu Rev Biochem. 1998;67:753-791.
3. Baker JC, Harland RM. A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev. 1996;10:1880-1889.
4. Graff JM, Bansal A, Melton DA. Xenopus Mad proteins transduce distinct subsets of signals for the TGF-β superfamily. Cell. 1996;85:479-487.
5. Zhang Y, Feng X, We R, Derynck R. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature. 1996;383:168-172.
6. Kretzschmar M, Liu F, Hata A, Doody J, Massague J. The TGFβ family mediators Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev. 1997;11:984-995.
7. Suzuki A, Chang C, Yingling JM, Wang XF, Hemmati BA. Smad5 induces ventral fates in Xenopus embryo. Dev Biol. 1997;184:402-405.
8. Cashman JD, Clark-Lewis I, Eaves AC, Eaves CJ. Differentiation stage-specific regulation of primitive human hematopoietic progenitors cycling by exogenous and endogenous inhibitors in an in vivo model. Blood. 1999;94:3722-3729.
9. Keller JR, Mcniece IK, Sill KT, et al. Transforming growth factor β directly regulates primitive murine hematopoietic cell proliferation. Blood. 1990;75:596-602.
10. Sitnicka E, Ruscetti FW, Priestley GV, Wolf NS, Bartelmez SH. Transforming growth factor β1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells. Blood. 1996;88:82-88.
11. Fortunel N, Batard P, Hatzfeld A, et al. High proliferative potential-quiescent cells: A working model to study primitive quiescent hematopoietic cells. J Cell Sci. 1998;111:1867-1875.
12. Bruno E, Horrigan SK, Van Den Berg D, et al. The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-β on human hematopoiesis. Blood. 1998;91:1917-1923.
13. Yang X, Castilla LH, Xu XL. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development. 1999;126:1571-1580.
14. Chang H, Huylebroeck D, Verschueren K, Guo QX, Matzuk MM, Zwijsen A. Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development. 1999;126:1631-1642.
15. Bradley TR, Hodgson GS. Detection of primitive macrophage progenitor cells in mouse bone marrow. Blood. 1979;54:1446-1450.
16. Palis J, Chan RJ, Koniski A, Pattel R, Starr M, Yoder MC. Spatial and temporal emergence of high proliferative potential hematopoietic precursors during murine embryogenesis. Proc Natl Acad Sci U S A. 2001;98:4528-4533.
17. Keller G, Kennedy M, Papayannopoulou T, Wiles MV. Hematopoietic commitment during embryonic stem cells differentiation in culture. Mol Cell Biol. 1993;13:473-486.
18. Yang X, Sun Y, Zhou J, et al. Establishment of murine Smad5 double knockout ES cells and the studies on their properties. Sci China C Life Sci. 2001;44:121-129.
19. Wiles MV, Keller G. Multiple hematopoietic lineage develop from embryonic stem (ES) cells in culture. Development. 1991;111:259-267.
20. Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G. A common precursor for hematopoietic and endothelial cells. Development. 1998;125:725-732.
21. Faloon P, Arentson E, Kazarov A, et al. Basic fibroblast growth factor positively regulates hematopoietic development. Development. 2000;127:1931-1941.
22. Robertson SM, Kennendy M, Shannon JM, Keller G. A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-1. Development. 2000;127:2447-2459.
23. Kennedy M, Firpo M, Keller G. A common precursor for primitive erythropoiesis and definitive haematopoiesis. Nature. 1997;386:488-493.
24. Wilkinson DG, Bhatt S, Herrmann BG. Expression pattern of the mouse T gene and its role in mesoderm formation. Nature. 1990;343:657-659.
25. Robb L, Lyons I, Li R, et al. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc Natl Acad Sci U S A. 1995;92:7075-7079.
26. Shivdasani RA, Mayer EL, Orkin SH. Absence of blood formation in mice lacking the T-cell leukemia oncoprotein tal-1/SCL. Nature. 1995;373:432-434.
27. Palis J, Robertson S, Kennedy M, Wall C, Keller G. Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. Development. 1999;126:5073-5081.
28. Pevny L, Simon MC, Robertson E, et al. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature. 1991;349:257-260.
29. Goumans MJ, Zwijsen A, Rooijen MA, Huylebroeck D, Roelen BAJ, Mummery CL. TGF-β signaling in extraembryonic mesoderm is required for yolk sac vasculogenesis in mice. Development. 1999;126:3473-3483.
30. Tsai F-Y, Keller G, Kuo FC, et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature. 1994;371:221-226.
31. Tsai F-Y, Orkin SH. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood. 1997;89:3636-3643.
32. Wang Q, Stacy T, Binder M, et al. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci U S A. 1996;93:3444-3449.
33. Okuda T, Deursen J, Hiebert SW, et al. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 1996;84:321-330.
34. Hatzfeld J, Li ML, Brown EL, et al. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor β1 or Rb oligonucleotides. J Exp Med. 1991;174:925-929.
35. Fortunel N, Hatzfeld J, Aoustin L, et al. Specific dose-response effects of TGF-β1 on developmentally distinct hematopoietic stem/progenitor cells from human umbilical cord blood. Hematol J. 2000;1:126-134.
36. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ. Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice. Development. 1995;121:1845-1854.
37. Oshima M, Oshima H, Taketo MM. TGF-β receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol. 1996;179:297-302.
38. Larsson J, Goumans MJ, Sjostrand LJ, et al. Abnormal angiogenesis but intact hematopoietic potential in TGF-β type I receptor-deficient mice. EMBO J. 2001;20:1663-1673.
39. Li W, Chen F, Nagarajan RP, Liu X, Chen Y. Characterization of the DNA-binding property of Smad5. Biochem Biophys Res Commun. 2001;286:1163-1169.
40. Slager HG, Freund E, Buiting AMJ, Fejien A, Mummery CL. Secretion of transforming growth factor-β isoforms by embryonic stem cells: Isoform and latency are dependent on direction of differentiation. J Cell Physiol. 1993;156:247-256.
41. 6A integrin splice variant in developing embryonic stem cell aggregates and correlation with cardiac muscle differentiation. Differentiation. 1999;64:173-184.
42. Jacobsen SE, Ruscetti FW, Dubois CM, Lee J, Boone TC, Keller JR. Transforming growth factor-β trans-modulates the expression of colony stimulating factor receptors on murine hematopoietic progenitor cell lines. Blood. 1991;77:1706-1716.
43. + hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia. Blood. 1996;88:4534-4546.
44. Rooke HM, Vitas MR, Crosier PS, Crosier KE. The TGF-β type II receptor in chronic myeloid leukemia: Analysis of microsatellite regions and gene expression. Leukemia. 1999;13:535-541.
45. DeCouteau JF, Knaus PI, Yankelev H, et al. Loss of functional cell surface transforming growth factor β (TGF-β) type I receptor correlates with insensitivity to TGF-β in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 1997;94:5877-5881.
46. Lagneaux L, Delforge A, Bron D, Massy M, Bernier M, Strykmans P. Heterogenous response of B lymphocytes to transforming growth factor-β in B-cell chronic lymphocytic leukaemia: Correlation with the expression of TGF-β receptors. Br J Haematol. 1997;97:612-620.
47. Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H. The t(3; 21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-β-mediated growth inhibition of myeloid cells. Blood. 1998;92:4003-4012.
48. Jakubowiak A, Pouponnot C, Berguido F, et al. Inhibition of the TGF-β1 signaling pathway by the AML1/ETO leukemia-associated fusion protein. J Biol Chem. 2000;275:40282-40287.
49. Hejlik DP, Kottickal LV, Liang H, et al. Localization of SMAD5 and its evaluation as a candidate myeloid tumor repressor. Cancer Res. 1997;57:3779-3783.
50. Zavadil J, Brezinova J, Svoboda P, Zemanova Z, Michalova K. Smad5, a tumor repressor candidate at 5q31.1, is hemizygously lost and not mutated in the retained allele in human leukemia cell line HL60. Leukemia. 1997;11:1187-1192.
51. Winnier G, Blessing M, Labosky PA, Hogan BLM. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 1995;9:2105-2116.
52. Johansson BM, Wiles MV. Evidence for involvement of activin A and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development. Mol Cell Biol. 1995;15:141-151.
53. Li F, Lu S, Vida L, Thomson JA, Honig GR. BMP4 induces efficient hematopoietic differentiation of rhesus monkey embryonic stem cells in vitro. Blood. 2001;98:335-342.
54. Adelman CA, Chattopadhyay S, Bieker JJ. The BMP/BMPR/Smad pathway directs expression of the erythroid-specific EKLF and GATA1 transcription factors during embryoid body differentiation in serum-free media. Development. 2002;129:539-549.
55. Huber TL, Zhou Y, Mead PE, Zon LI. Cooperative effects of growth factors involved in the induction of hematopoietic mesoderm. Blood. 1998;92:4128-4137.
56. + hematopoietic progenitors. Blood. 1995;86:4454-4467.
57. Begley CG, Visvader J, Green AR, et al. Molecular cloning and chromosomal localization of the murine homolog of the human helix-loop-helix gene SCL. Proc Natl Acad Sci U S A. 1991;88:869-873.
58. Tsai SF, Martin DIK, Zon L, D'Andrea AD, Wong GG, Orkin SH. Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells. Nature. 1989;339:446-451.
59. Andrews NG, Erdjument-Bromage H, Davidson MB, Tempst P, Orkin SH. Erythroid transcription factor NF-E2 is a haematopoietic-specific basicleucine zipper protein. Nature. 1993;362:722-728.
60. Weiss MJ, Keller G, Orkin SH. Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells. Genes Dev. 1994;8:1184-1197.
61. Kuramochi S, Ikawa Y, Todokoro K. Characterization of murine erythropoietin receptor genes. J Mol Biol. 1990;216:567-575.
62. Schmitt RM, Bruyns E, Snodgrass HR. Hematopoietic development of embryonic stem cells in vitro: Cytokine and receptor gene expression. Genes Dev. 1991;5:728-740.
63. Park LS, Martin U, Sorensen R, et al. Cloning of the low-affinity murine granulocyte-macrophage colony-stimulating factor receptor and reconstitution of a high-affinity receptor complex. Proc Natl Acad Sci U S A. 1992;89:4295-4299.
64. Roelen BAJ, Lin HY, Knezevic V, Freund E, Mummery CL. Expression of TGFβs and their receptors during implantation and organogenesis of the mouse embryo. Dev Biol. 1994;166:716-728.